Skip to main content

Meet the Analyst: Dr. Tara Speranza, Bell Potter Analyst Part 2

Grady Wulff
February 23, 2023

Continue on to learn about the remaining stocks, Microba Life Sciences (ASX:MAP) and Monash IVF (ASX:MVF), as well as what to expect from these companies in 2023.

In this video, Dr. Tara discusses:
– (0:34) Impacts of Ferring’s FDA approval on Microba
– (5:30) Drivers behind Microba’s increase in revenue
– (7:12) What 2023 looks like for Monash IVF
– (8:39) Monash IVF’s rating
– (11:45) Monash IVF’s impact from legal action

Note: This interview was filmed on 7 February 2023.

Morning Bell 7 April

Bell Direct
April 7, 2025

Weekly Wrap 4 April

Bell Direct
April 4, 2025

Morning Bell 3 April

Bell Direct
April 3, 2025

Morning Bell 2 April

Grady Wulff
April 2, 2025

Morning Bell 1 April

Grady Wulff
April 1, 2025

Morning Bell 31 March

Bell Direct
March 31, 2025

Weekly Wrap 28 March

Bell Direct
March 28, 2025

Morning Bell 27 March

Bell Direct
March 27, 2025

Morning Bell 26 March

Sam Kanaan
March 26, 2025

Morning Bell 25 March

Grady Wulff
March 25, 2025

Morning Bell 24 March

Grady Wulff
March 24, 2025

Weekly Wrap 21 March

Bell Direct
March 21, 2025